Skip to main content

What Are Wall Street Analysts' Target Price for Corteva Stock?

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Indianapolis, Indiana-based Corteva, Inc. (CTVA) provides seed and crop protection solutions, which engages in the agriculture industry and food supply. Valued at $54.3 billion by market cap, the leading agricultural company offers seeds and crop protection products, as well as software solutions and digital services.

Shares of this agricultural chemical and seed major have underperformed the broader market over the past year. CTVA has gained 22.2% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 31%. However, in 2026, CTVA stock is up 23.6%, surpassing the SPX’s 8.3% rise on a YTD basis. 

 

Zooming in further, CTVA’s outperformance is apparent compared to First Trust Indxx Global Agriculture ETF (FTAG). The exchange-traded fund has gained about 18.7% over the past year. Moreover, the stock’s returns on a YTD basis outshine the ETF’s 14.5% gains over the same time frame.

www.barchart.com

On May 5, CTVA shares closed up by 2.7% after reporting its Q1 results. Its adjusted EPS of $1.50 topped Wall Street expectations of $1.18. The company’s revenue was $4.9 billion, topping Wall Street forecasts of $4.7 billion. CTVA expects full-year adjusted EPS in the range of $3.45 to $3.70.

For the current fiscal year, ending in December, analysts expect CTVA’s EPS to grow 9.9% to $3.67 on a diluted basis. The company’s earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters.

Among the 21 analysts covering CTVA stock, the consensus is a “Moderate Buy.” That’s based on 12 “Strong Buy” ratings, two “Moderate Buys,” and seven “Holds.” 

www.barchart.com

This configuration is less bullish than three months ago, with 14 analysts suggesting a “Strong Buy.” 

On May 8, Wells Fargo & Company (WFC) analyst Michael Sison maintained a “Buy” rating on CTVA and set a price target of $90, implying a potential upside of 8.7% from current levels.

The mean price target of $88.55 represents a 6.9% premium to CTVA’s current price levels. The Street-high price target of $97 suggests an upside potential of 17.1%.


On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.

 

More news from Barchart

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  265.82
-3.17 (-1.18%)
AAPL  294.80
+2.12 (0.72%)
AMD  448.29
-10.50 (-2.29%)
BAC  50.78
+0.23 (0.45%)
GOOG  383.82
-2.95 (-0.76%)
META  603.00
+4.14 (0.69%)
MSFT  407.77
-4.89 (-1.18%)
NVDA  220.78
+1.34 (0.61%)
ORCL  186.83
-7.01 (-3.62%)
TSLA  433.45
-11.55 (-2.60%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.